Patients with a high defibrillation threshold: Approaches to management
Implantable cardioverter‐defibrillators (ICDs) have revolutionized the prognosis for patients at elevated risk of ventricular tachyarrhythmias. For safety, defibrillation should be effective with a minimum of 10 J below the device's maximum energy. While modern ICDs rarely deliver ineffective s...
Gespeichert in:
Veröffentlicht in: | Pacing and clinical electrophysiology 2024-02, Vol.47 (2), p.222-232 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 232 |
---|---|
container_issue | 2 |
container_start_page | 222 |
container_title | Pacing and clinical electrophysiology |
container_volume | 47 |
creator | Vidal Margenat, Alejandro Zedan, Ahmed Schubert, Scott Gopani, Srushti Hariharan, Ramesh |
description | Implantable cardioverter‐defibrillators (ICDs) have revolutionized the prognosis for patients at elevated risk of ventricular tachyarrhythmias. For safety, defibrillation should be effective with a minimum of 10 J below the device's maximum energy. While modern ICDs rarely deliver ineffective shocks in primary prevention, the surge in managing severe heart failure patients has led to an increased number of patients with high defibrillation thresholds (DFTs). This article elucidates the potential causes of high DFT, including clinical factors, lead and device placement, the presence of a Left Ventricular Assist Device (LVAD), prolonged ventricular arrhythmias, shock vectors, waveform tilt, medications, and manufacturer‐specific options. We also detail management strategies, highlighting alternative shock coil placements, practical recommendations, and case studies from our institution. Our management algorithm suggests addressing preventable causes, re‐evaluating coil positions, considering non‐invasive system modifications, upgrading to a higher‐capacity device, and adding extra coil(s). |
doi_str_mv | 10.1111/pace.14936 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2920572629</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2926085942</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3166-fb2b24d0b525df1074606723b625a5383082e0799c5675f5d84966efddd23de33</originalsourceid><addsrcrecordid>eNp90E1LwzAABuAgipvTiz9ACl5EqOajSRNvY8wpDNxBzyFt0jWjHzNpGfv3ZnZ68GAuOeTJy8sLwDWCDyicx63KzQNKBGEnYIxoAmOOqDgFY4iSNOaEixG48H4DIWQwoedgRDgWiKdwDBYr1VnTdD7a2a6MVFTadRlpU9jM2aoKj20TdaUzvmwr_RRNt1vXqrw0PuraqFaNWps6_L8EZ4WqvLk63hPw8Tx_n73Ey7fF62y6jHOCGIuLDGc40TCjmOoCwTRhkKWYZAxTRQknkGMDUyFyylJaUM0TwZgptNaYaEPIBNwNuaHGZ298J2vrcxOaNqbtvcQCQ5pihkWgt3_opu1dE9odFIOcigQHdT-o3LXeO1PIrbO1cnuJoDzMKw_zyu95A745RvZZbfQv_dkzADSAna3M_p8ouZrO5kPoF8lsgyE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2926085942</pqid></control><display><type>article</type><title>Patients with a high defibrillation threshold: Approaches to management</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Vidal Margenat, Alejandro ; Zedan, Ahmed ; Schubert, Scott ; Gopani, Srushti ; Hariharan, Ramesh</creator><creatorcontrib>Vidal Margenat, Alejandro ; Zedan, Ahmed ; Schubert, Scott ; Gopani, Srushti ; Hariharan, Ramesh</creatorcontrib><description>Implantable cardioverter‐defibrillators (ICDs) have revolutionized the prognosis for patients at elevated risk of ventricular tachyarrhythmias. For safety, defibrillation should be effective with a minimum of 10 J below the device's maximum energy. While modern ICDs rarely deliver ineffective shocks in primary prevention, the surge in managing severe heart failure patients has led to an increased number of patients with high defibrillation thresholds (DFTs). This article elucidates the potential causes of high DFT, including clinical factors, lead and device placement, the presence of a Left Ventricular Assist Device (LVAD), prolonged ventricular arrhythmias, shock vectors, waveform tilt, medications, and manufacturer‐specific options. We also detail management strategies, highlighting alternative shock coil placements, practical recommendations, and case studies from our institution. Our management algorithm suggests addressing preventable causes, re‐evaluating coil positions, considering non‐invasive system modifications, upgrading to a higher‐capacity device, and adding extra coil(s).</description><identifier>ISSN: 0147-8389</identifier><identifier>EISSN: 1540-8159</identifier><identifier>DOI: 10.1111/pace.14936</identifier><identifier>PMID: 38291870</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Arrhythmias, Cardiac ; Congestive heart failure ; Defibrillators, Implantable ; Electric Countershock ; Heart-Assist Devices ; high defibrillation thresholds ; Humans ; implantable cardioverted defibrillators ; left ventricular assist device ; Prognosis ; Ventricle ; Ventricular Fibrillation - therapy ; ventricular tachyarrhythmias</subject><ispartof>Pacing and clinical electrophysiology, 2024-02, Vol.47 (2), p.222-232</ispartof><rights>2024 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3166-fb2b24d0b525df1074606723b625a5383082e0799c5675f5d84966efddd23de33</cites><orcidid>0009-0003-1446-1668</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpace.14936$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpace.14936$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38291870$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vidal Margenat, Alejandro</creatorcontrib><creatorcontrib>Zedan, Ahmed</creatorcontrib><creatorcontrib>Schubert, Scott</creatorcontrib><creatorcontrib>Gopani, Srushti</creatorcontrib><creatorcontrib>Hariharan, Ramesh</creatorcontrib><title>Patients with a high defibrillation threshold: Approaches to management</title><title>Pacing and clinical electrophysiology</title><addtitle>Pacing Clin Electrophysiol</addtitle><description>Implantable cardioverter‐defibrillators (ICDs) have revolutionized the prognosis for patients at elevated risk of ventricular tachyarrhythmias. For safety, defibrillation should be effective with a minimum of 10 J below the device's maximum energy. While modern ICDs rarely deliver ineffective shocks in primary prevention, the surge in managing severe heart failure patients has led to an increased number of patients with high defibrillation thresholds (DFTs). This article elucidates the potential causes of high DFT, including clinical factors, lead and device placement, the presence of a Left Ventricular Assist Device (LVAD), prolonged ventricular arrhythmias, shock vectors, waveform tilt, medications, and manufacturer‐specific options. We also detail management strategies, highlighting alternative shock coil placements, practical recommendations, and case studies from our institution. Our management algorithm suggests addressing preventable causes, re‐evaluating coil positions, considering non‐invasive system modifications, upgrading to a higher‐capacity device, and adding extra coil(s).</description><subject>Arrhythmias, Cardiac</subject><subject>Congestive heart failure</subject><subject>Defibrillators, Implantable</subject><subject>Electric Countershock</subject><subject>Heart-Assist Devices</subject><subject>high defibrillation thresholds</subject><subject>Humans</subject><subject>implantable cardioverted defibrillators</subject><subject>left ventricular assist device</subject><subject>Prognosis</subject><subject>Ventricle</subject><subject>Ventricular Fibrillation - therapy</subject><subject>ventricular tachyarrhythmias</subject><issn>0147-8389</issn><issn>1540-8159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90E1LwzAABuAgipvTiz9ACl5EqOajSRNvY8wpDNxBzyFt0jWjHzNpGfv3ZnZ68GAuOeTJy8sLwDWCDyicx63KzQNKBGEnYIxoAmOOqDgFY4iSNOaEixG48H4DIWQwoedgRDgWiKdwDBYr1VnTdD7a2a6MVFTadRlpU9jM2aoKj20TdaUzvmwr_RRNt1vXqrw0PuraqFaNWps6_L8EZ4WqvLk63hPw8Tx_n73Ey7fF62y6jHOCGIuLDGc40TCjmOoCwTRhkKWYZAxTRQknkGMDUyFyylJaUM0TwZgptNaYaEPIBNwNuaHGZ298J2vrcxOaNqbtvcQCQ5pihkWgt3_opu1dE9odFIOcigQHdT-o3LXeO1PIrbO1cnuJoDzMKw_zyu95A745RvZZbfQv_dkzADSAna3M_p8ouZrO5kPoF8lsgyE</recordid><startdate>202402</startdate><enddate>202402</enddate><creator>Vidal Margenat, Alejandro</creator><creator>Zedan, Ahmed</creator><creator>Schubert, Scott</creator><creator>Gopani, Srushti</creator><creator>Hariharan, Ramesh</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0003-1446-1668</orcidid></search><sort><creationdate>202402</creationdate><title>Patients with a high defibrillation threshold: Approaches to management</title><author>Vidal Margenat, Alejandro ; Zedan, Ahmed ; Schubert, Scott ; Gopani, Srushti ; Hariharan, Ramesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3166-fb2b24d0b525df1074606723b625a5383082e0799c5675f5d84966efddd23de33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Arrhythmias, Cardiac</topic><topic>Congestive heart failure</topic><topic>Defibrillators, Implantable</topic><topic>Electric Countershock</topic><topic>Heart-Assist Devices</topic><topic>high defibrillation thresholds</topic><topic>Humans</topic><topic>implantable cardioverted defibrillators</topic><topic>left ventricular assist device</topic><topic>Prognosis</topic><topic>Ventricle</topic><topic>Ventricular Fibrillation - therapy</topic><topic>ventricular tachyarrhythmias</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vidal Margenat, Alejandro</creatorcontrib><creatorcontrib>Zedan, Ahmed</creatorcontrib><creatorcontrib>Schubert, Scott</creatorcontrib><creatorcontrib>Gopani, Srushti</creatorcontrib><creatorcontrib>Hariharan, Ramesh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pacing and clinical electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vidal Margenat, Alejandro</au><au>Zedan, Ahmed</au><au>Schubert, Scott</au><au>Gopani, Srushti</au><au>Hariharan, Ramesh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patients with a high defibrillation threshold: Approaches to management</atitle><jtitle>Pacing and clinical electrophysiology</jtitle><addtitle>Pacing Clin Electrophysiol</addtitle><date>2024-02</date><risdate>2024</risdate><volume>47</volume><issue>2</issue><spage>222</spage><epage>232</epage><pages>222-232</pages><issn>0147-8389</issn><eissn>1540-8159</eissn><abstract>Implantable cardioverter‐defibrillators (ICDs) have revolutionized the prognosis for patients at elevated risk of ventricular tachyarrhythmias. For safety, defibrillation should be effective with a minimum of 10 J below the device's maximum energy. While modern ICDs rarely deliver ineffective shocks in primary prevention, the surge in managing severe heart failure patients has led to an increased number of patients with high defibrillation thresholds (DFTs). This article elucidates the potential causes of high DFT, including clinical factors, lead and device placement, the presence of a Left Ventricular Assist Device (LVAD), prolonged ventricular arrhythmias, shock vectors, waveform tilt, medications, and manufacturer‐specific options. We also detail management strategies, highlighting alternative shock coil placements, practical recommendations, and case studies from our institution. Our management algorithm suggests addressing preventable causes, re‐evaluating coil positions, considering non‐invasive system modifications, upgrading to a higher‐capacity device, and adding extra coil(s).</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38291870</pmid><doi>10.1111/pace.14936</doi><tpages>11</tpages><orcidid>https://orcid.org/0009-0003-1446-1668</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0147-8389 |
ispartof | Pacing and clinical electrophysiology, 2024-02, Vol.47 (2), p.222-232 |
issn | 0147-8389 1540-8159 |
language | eng |
recordid | cdi_proquest_miscellaneous_2920572629 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Arrhythmias, Cardiac Congestive heart failure Defibrillators, Implantable Electric Countershock Heart-Assist Devices high defibrillation thresholds Humans implantable cardioverted defibrillators left ventricular assist device Prognosis Ventricle Ventricular Fibrillation - therapy ventricular tachyarrhythmias |
title | Patients with a high defibrillation threshold: Approaches to management |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T21%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patients%20with%20a%20high%20defibrillation%20threshold:%20Approaches%20to%20management&rft.jtitle=Pacing%20and%20clinical%20electrophysiology&rft.au=Vidal%20Margenat,%20Alejandro&rft.date=2024-02&rft.volume=47&rft.issue=2&rft.spage=222&rft.epage=232&rft.pages=222-232&rft.issn=0147-8389&rft.eissn=1540-8159&rft_id=info:doi/10.1111/pace.14936&rft_dat=%3Cproquest_cross%3E2926085942%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2926085942&rft_id=info:pmid/38291870&rfr_iscdi=true |